Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease

被引:27
作者
Critchley, Rebecca J. [1 ]
Khan, Sameer K. [1 ]
Yarnall, Alison J. [2 ]
Parker, Martyn J. [3 ]
Deehan, David J. [1 ]
机构
[1] Newcastle Tyne Hosp NHS Trust, Dept Trauma & Orthopaed, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Newcastle Univ, Inst Neurosci, Clin Ageing Res Unit, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England
[3] Peterborough & Stamford Hosp NHS Fdn Trust, Dept Trauma & Orthopaed, Peterborough PE3 9GZ, Cambs, England
关键词
Parkinson's disease; bone mineral density; falls; hip fractures; FEMORAL-NECK; RISK-FACTORS; REPLACEMENT; BONE; HEAD; CARE;
D O I
10.1093/bmb/ldv029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Hip fractures can be debilitating, especially in patients with pre-existing Parkinson's disease; they have reportedly worse outcomes than non-Parkinson's disease patients. Sources of data: A computerized literature search on PubMed, Medline, Embase, and CINAHL, supplemented by a manual search of related publications. Areas of agreement: Parkinson's disease patients were found to have significantly lower bone mineral density; higher incidence of falls and hip fractures; delays to receiving their Parkinson's disease medication and surgery; higher risk of pneumonia, urinary infection, pressure sores, post-operative mortality; surgical complications and sequelae, including failed fixation, dislocation, longer hospital stay, re-operation; and increased risk of contralateral hip fracture. Areas of controversy: Regain of mobility and return to previous residential status have been variably reported. Growing points: All Parkinson's disease patients should be screened and considered for primary prevention treatment. On admission with hip fractures, attention should be paid to avoid delays to medication, ensuring safe anaesthetic and timely surgery, and post-operative chest physiotherapy and mobilization. Research: Research is needed in minimizing the bone-resorptive effects of anti-Parkinson's disease medication.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 56 条
[1]   Bone and mineral metabolism in older adults with Parkinson's disease [J].
Abou-Raya, Suzan ;
Helmii, Madihah ;
Abou-Raya, Anna .
AGE AND AGEING, 2009, 38 (06) :675-680
[2]  
[Anonymous], 2011, J AM GERIATR SOC, V59
[3]  
[Anonymous], PARK PREV UK
[4]   Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study [J].
Arbouw, M. E. L. ;
Movig, K. L. L. ;
van Staa, T. P. ;
Egberts, A. C. G. ;
Souverein, P. C. ;
de Vries, F. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (07) :2197-2204
[5]   Risk for Femoral Fractures in Parkinson's Disease Patients with and without Severe Functional Impairment [J].
Benzinger, Petra ;
Rapp, Kilian ;
Maetzler, Walter ;
Koenig, Hans-Helmut ;
Jaensch, Andrea ;
Klenk, Jochen ;
Buechele, Gisela .
PLOS ONE, 2014, 9 (05)
[6]   Is there an increased risk of hip fracture in Parkinson's disease? A nationwide inpatient sample [J].
Bhattacharya, Rajib K. ;
Dubinsky, Richard M. ;
Lai, Sue Min ;
Dubinsky, Hilary .
MOVEMENT DISORDERS, 2012, 27 (11) :1440-1443
[7]   Parkinson's disease and risk of hip fracture: An 8-year follow-up study in Taiwan [J].
Chen, Yen-Yu ;
Cheng, Pei-Yu ;
Wu, Shey-Lin ;
Lai, Chien-Hsu .
PARKINSONISM & RELATED DISORDERS, 2012, 18 (05) :506-509
[8]  
CHRISTODOULOU NA, 1984, CLIN ORTHOP RELAT R, P215
[9]  
COUGHLIN L, 1980, CLIN ORTHOP RELAT R, P192
[10]   Type of Hip Fracture in Patients With Parkinson Disease is Associated With Femoral Bone Mineral Density [J].
Di Monaco, Marco ;
Vallero, Fulvia ;
Di Monaco, Roberto ;
Tappero, Rosa ;
Cavanna, Alberto .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (12) :2297-2301